Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal lupus syndromes.

Jill P Buyon1, Robert M Clancy

  • 1Department of Medicine, New York University School of Medicine, New York, New York, USA. jill.buyon@med.nyu.edu

Current Opinion in Rheumatology
|September 10, 2003
PubMed
Summary

Neonatal lupus syndromes, though rare, offer insights into disease mechanisms. Research shows maternal autoantibodies alone don't cause congenital heart block, suggesting fetal factors are crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Children exposed to hydroxychloroquine in utero show no signs of retinal toxicity at age 5.

Lupus science & medicine·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

Clinical, Histologic, and Serological Predictors of Renal Function Loss in Lupus Nephritis.

Arthritis care & research·2026
Same author

A population-scale atlas of blood and tissue in lupus nephritis.

bioRxiv : the preprint server for biology·2026
Same author

Transcription factor Etv3 controls the tolerogenic function of dendritic cells.

Science (New York, N.Y.)·2026

Area of Science:

  • Immunology
  • Cardiology
  • Pediatrics

Background:

  • Neonatal lupus syndromes (NLS) present a unique model for studying autoimmune diseases from basic research to clinical application.
  • Maternal autoantibodies, specifically anti-SSA/Ro and anti-SSB/La, are associated with fetal heart conduction abnormalities, but the risk of congenital heart block is lower than previously assumed.

Purpose of the Study:

  • To review recent advances in understanding the pathogenesis and clinical manifestations of neonatal lupus syndromes.
  • To highlight the complexities of antibody-mediated injury in fetal cardiac development and the role of fetal factors.
  • To discuss current and emerging diagnostic and therapeutic strategies for NLS.

Main Methods:

  • Review of recent peer-reviewed publications on neonatal lupus syndromes, encompassing basic science and clinical studies.
  • Analysis of antibody detection rates in mothers and the incidence of congenital heart block in offspring.
  • Examination of in vivo and in vitro evidence for the pathogenic cascade of antibody-mediated cardiac injury.

Main Results:

  • While anti-SSA/Ro-SSB/La antibodies are common in mothers of affected infants, the absolute risk of congenital heart block is low (≤1 in 50).
  • Evidence suggests a multi-step pathogenic process involving cardiocyte apoptosis, antigen translocation, antibody binding, macrophage activation, and fibroblast transdifferentiation.
  • The spectrum of cardiac abnormalities in NLS is expanding, including progressive heart block and late-onset cardiomyopathy; incomplete blocks can worsen postnatally.

Conclusions:

  • Congenital heart block in NLS is likely multifactorial, involving both maternal antibodies and fetal factors.
  • Early detection of first-degree heart block via echocardiography may improve risk assessment in pregnant women.
  • Further research, including larger clinical trials for prophylactic therapies and national registries, is essential for advancing NLS management.

Related Experiment Videos